Linagliptin for type 2 diabetes is safe to use

被引：0
|
作者：
Pettersen, Petter Morten
机构：
来源：
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2019年 / 139卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [31] Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
    Silke Retlich
    Vincent Duval
    Ulrike Graefe-Mody
    Christian Friedrich
    Sanjay Patel
    Ulrich Jaehde
    Alexander Staab
    Clinical Pharmacokinetics, 2015, 54 : 737 - 750
  • [32] Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation
    Barnett, Anthony H.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 149 - 159
  • [33] Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
    Retlich, Silke
    Duval, Vincent
    Graefe-Mody, Ulrike
    Friedrich, Christian
    Patel, Sanjay
    Jaehde, Ulrich
    Staab, Alexander
    CLINICAL PHARMACOKINETICS, 2015, 54 (07) : 737 - 750
  • [34] Pharmacology, Efficacy, and Safety of Linagliptin for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (03) : 358 - 367
  • [35] Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
    von Websky, Karoline
    Reichetzeder, Christoph
    Hocher, Berthold
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 681 - 694
  • [36] Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials
    McGill, Janet B.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2012, 3 (04) : 113 - 124
  • [37] Linagliptin and Glimepiride Equally Effective for Adults with Type 2 Diabetes Mellitus
    Slawson, David C.
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (05) : 309 - 310
  • [38] Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function
    Shigiyama, Fumika
    Kumashiro, Naoki
    Miyagi, Masahiko
    Iga, Ryo
    Kobayashi, Yuka
    Kanda, Eiichiro
    Uchino, Hiroshi
    Hirose, Takahisa
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (03) : 330 - 340
  • [39] Effects of linagliptin vs glimepiride stratified by prior insulin secretagogue use in the cardiovascular outcome study of linagliptin versus glimepiride in type 2 diabetes (CAROLINA) trial
    McGuire, D. K.
    Rosenstock, J.
    Johansen, O. E.
    Zinman, B. J.
    Khunti, K.
    Mattheus, M.
    Lund, S. S.
    Espeland, M. A.
    Marx, N.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3356 - 3356
  • [40] Safety and Efficacy of Linagliptin in Type 2 Diabetes Patients with Severe Renal Impairment
    Sloan, Lance
    Newman, Jennifer
    Sauce, Christophe
    Von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans J.
    DIABETES, 2011, 60 : A114 - A114
12345